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Abstract: We derived a novel approach to monitor disulfide bond 
reduction in the vicinity of aromatic cluster(s) by using the near-UV 
range (266–293 nm) of ECD spectra. By using combined NMR- and 
ECD-spectroscopy we have determined the 3D-fold characteristics 
and the associated reduction rate constants (k) of E19_SS – a highly 
thermostable; disulfide bond reinforced 39-amino acid long 
Exenatide mimetic – and its N-terminally truncated derivatives at 
different experimental conditions. Single SS-bond reduction of the 
E19_SS model (using 18-fold excess of TCEP, pH = 7, 37 °C) takes 
hours, 20-30 times longer than expected, thus would not reach 
completion applying the commonly used reduction protocols. We 
found that structural, steric and electrostatic factors influence the 
reduction rate, resulting in magnitude differences in reduction half-
times (900 > t½ > 1 min) even for structurally similar, well-folded 
derivatives of a small model-protein. 
Introduction 
Forming a multitude of temporary H-bonds, H2O molecules 
interact with backbone amides and thus, loosen the polar 
intramolecular interactions (salt-bridges, H-bonds, 
cation/anion↔π-interactions, etc.) holding together proteins’ 
secondary and tertiary structures. Structural disulfide bonds – 
stable in harsh oxidative extracellular environment – on the 
contrary, maintain proteins’ native fold by fixing and protecting 
them from thermal fluctuation induced elevated internal 
dynamics. SS-bond formation is perhaps the most fundamental 
post-translational modification that stabilizes globular proteins 
3D-fold. The absence of regulated disulfide formation leads to 
diseases including diabetes [1], cancer [2], neurodegenerative 
conditions [3] and cardiovascular diseases [4]. Non-native SS-
bond pairing evokes backbone misfolding, jeopardizing both 
function and bioactivity, although some proteins may present 
alternative disulfide states and still get similarly well-folded forms. 
[5] In protein evolution the presence of disulfide bonds shows a 
significant correlation with complexity of the organism. [6] 
Approximately 50% of all the cysteines found in proteins form 
disulfide-bonds [7], thereby these cysteines become the most 
conserved among all amino-acid, despite being added late to the 
genetic code during protein evolution. [8] Due to the unique 
pairing pattern of cysteines, SS-bonds stabilize proteins’ 3D-fold 
unambiguously [9].  
Contrary to the structural disulfides, redox-active disulfides 
are highly dynamic and their formation is reversible. The redox 
potential of the surrounding environment controls these proteins 
regulation and cellular localization. [10] Intramolecular formation 
of these redox-active disulfides is common for oxoreductases 
(thioredoxin [11] or glutaredoxin [12] family) and allosteric 
disulfides [13][14][15], while the intermolecular disulfide linkage 
results in glutathionylated [16] or cysteinylated [17] small 
molecule-protein adducts. The redox potential and stability of the 
SS-bond is highly dependent on several factors, such as the 
pKa of the tiols (the standard pKa is 8.5, however pKa values 
are known from 3.5 to 12.8 depending on local environment) [18], 
the SS-bond introduced strain of the protein structure and the 
entropic cost of the SS-bond formation. [19][20] The Cys 
residues of an SS-bond are typically distant in the primary 
sequence, 49% of the SS-bond forming cysteines are more than 
25 residues apart from each other. [21] Disulfide-bond formation 
is thermodynamically more favorable if the cysteines are already 
in spatial vicinity in the tertiary structure before oxidation by the 
native fold itself [22], otherwise – in the absence of chaperones 
assisting the folding [23] - the protein precipitates. Adjacent 
cysteines oxidized to SS-bond are rare, though examples can be 
found among enzymes, receptors and toxins. [24][25] The 
disulfide bond or SS-bond pattern in prokaryotic proteins is 
formulated by ribosomal mRNA translation followed by oxidation 
and posttranslational modifications catalyzed by various 
enzymes located in the periplasm (DsbC, DsbG, DsbD) [26] or 
cytoplasm (DsbA, DsbB). [27][28] In eukaryotic species, this 
process is performed in specific cell organelles, such as the 
mitochondria (Mia40, ERV1), endoplasmic reticulum (PDI, ERO1, 
Erv2) and chloroplasts (PSI, PSII, LTO1, LQY1, CYO1). [29]  
For hundreds of proteins of known 3D structures, SS-
bonds form the nucleus of their core. Hydrophobic and/or 
aromatic residues (e.g. Trp and Tyr) may condense around the 
SS-bond and form the network of key interactions that 
determines the 3D-structure of a large number of different 
protein families. [21] In at least 50% of the protein families, this 
type of interaction is invariant. In dozen of proteins (e.g. Tick 
anticoagulant peptide [30], phospholipase A2 [31]) SS-unit(s) 
are reinforced by associated aromatic-aromatic interactions 
[32][33] and vica-versa. For instance, Tyr92 of RNase-A 
effectively shields the solvent-exposed nearby SS-bond (Cys40-
Cys95) from reducing agents and thus, Tyr92 helps to maintain 
the native fold of the protein. [34]  
When SS-bonds are reduced, the free thiol groups of 
cysteines often adopt an ensemble of local conformers 
loosening neighboring residues compactness as well. In the era 
of manufacturing recombinant proteins (e.g. Insulin), SS-bond 
cyclized peptides (e.g. vasopressin, oxytocin, desmopressin, 
octreotide) [35] and human monoclonal IgG antibodies [36] on a 
large scale by biopharmaceutical industry, it is vital to have 
reliable and fully tested methods for SS-bond reduction in an 
aqueous solution.  
Besides -mercaptoethanol or DTT, more recently 
TCEP is commonly used as it has an elevated chemical stability 
and reduces SS-bonds more effectively and quickly even at 
lower pHs. The non-volatile, SH-free and thus odorless TCEP is 
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hydrophilic, soluble (>24 h) in aqueous solutions and buffers at a 
wide pH range (2.0 < pH < 9.0) [37], but it is less likely to 
permeate the hydrophobic protein core, which limits its 
applicability. Esterification to trimethyl TCEP (tmTCEP) could be 
a proper alternative of TCEP for SS-bond reduction in a 
hydrophobic medium and for non-accessible, core disulfide-
bonds. [38] TCEP is claimed to selectively and completely 
reduce water-soluble alkyl disulfides over a wide pH range within 
a few minutes (< 5 min). [39] Some protocols recommend using 
1–100 molar equivalents of TCEP over protein concentration. 
[40][41] The reduction time and the proper temperature greatly 
depends on the nature of the protein, but generally, elevated 
temperature and/or TCEP [42] concentration and longer times 
make the reduction more complete, but these conditions also 
initiate a multitude of side reactions, which are yet poorly 
described.  
Exendin-4 [43] or Exenatide [44] (synthetic name) – 
used in clinical practice since 2005 - is an incretin mimetic [45] 
GLP-1 analogue, a ninety-three residue long peptide with 
complex physiological actions [46] in multiple organs, resulting in 
an effective treatment of type 2 Diabetes Mellitus [47]. Exenatide 
acts as an agonist of the GLP-1 receptor [48] (GLP-1R). Its 
amphipathic helix binds to the extracellular domain of the GLP-
1R, the mainly unstructured N-terminal activates the receptor 
[49] while the structure stabilizing Trp-cage [50][51] fold is not 
directly involved in interactions to GLP-1R. [52][53] We have 
synthesized and studied the 3D-fold of several dozens of Trp-
cage folds including Exenatide-4 analogs such as E19 [54][55], 
a 39 amino acid comprising protein of comparable bioactivity but 
of improved water solubility. As a 3D-fold compactness 
enhancing “natural tool”, we introduced two solvent exposed Cys 
residues into E19 making E19_SS (Figure 1) looping residue 18 
 
Figure 1. a) Structure ensemble of E19_SS and b) amino acid sequences of 
GLP-1, Exenatide, the parent E19 and its truncated derivatives E11, E5, E2 as 
well as their SS analogues: E19_SS, E11_SS, E5_SS, E2_SS and their 
reduced 2SH analogues: E19_2SH, E11_2SH, E5_2SH, E2_2SH. The 
position of SS-bridge is highlighted by stick representation and underlined as 
C. Sequences of E19 is divided into 6 major parts: 1) 1-8 unstructured N-
terminal, 2) 9-14 outer helix, 3) 15-17 kink region, 4) 18-27 inner helix, 5) 28-
34 310 helix, 6) poly-proline region. This apportionment of the sequence 
coincides with the truncation of the peptides. 
to 39 in E19_A18C_S39C (E19_2SH). E19_2SH oxidized to 
E19_SS spontaneously by atmospheric O2 dissolved in water at 
room temperature. The SS-bond of E19_SS extends the 
hydrophobic core of the native Trp-fold in the spatial proximity of 
Tyr22, surrounded by explicit negative charges (Glu15, Glu16, 
Glu17). Although E19_SS is small in size, (MW: 4334.9 Da) its 
reduction took several hours to reach equilibrium, by using >10 
molar excess of TCEP in water at room temperature. As the SS-
bond reduction time turned out to be significantly longer than 
expected based on literature data and common laboratory 
practice, we launched a comparative study including 3 designed 
and truncated analogs of E19_SS, namely E11_SS, E5_SS and 
E2_SS as well. Note that the model systems thus created 
(Figure 1) oxidize spontaneously and rapidly adopt the Trp-cage 
3D-fold. [56] Moreover, the “loop size” created by the SS-bond, 
in other words, the number of residues between the two reacting 
cysteines is 20 amino-acid, close to the average value (~17) 
observed in thousands of proteins. [57]  
E11_SS was designed by removing the ‘HGEGTFTS-
‘tail, the unstructured GLP-1R activating N-terminal eight 
residues of E19_SS. Shortened by an additional six residues 
eliminates also removes the outer-helical part of E19_SS, 
namely the ‘HGEGTFTS-DLSKQM-‘subunit [56] affording 
E5_SS. Although fourteen residues shorter than E19-SS, E5_SS 
still adopts a compact Trp-cage fold and comprises the entire 
interface for binding to GLP-1R. [58] Finally, in E2_SS, the entire 
N-terminus preceding Cys18 of E19_SS was omitted, namely 
‘HGEGTFTS-DLSKQ-EEE-‘ was cleaved, to get a folded protein 
with the SS-bond at its surface fully exposed, considered as a 
construct ready for a rapid SS-bond reduction (Figure 1).  
Hereby we discuss the detailed atomic structure and 
properties both the oxidized and the reduced form in comparison 
with the parent miniproteins. We introduce possible 
spectroscopic approaches that make the monitoring of the 
reduction progress available, fast and easy. We define and 
compare the reduction kinetics of the four model proteins of 
different -helical length. The effect of the compactness on the 
protein fold, the accessibility and the local explicit charges of the 
SS-bond, the reagent type on reduction rate and the mechanism 
are explanted in this paper. 
Results and Discussion 
3D-fold as characterized by far-UV ECD spectra 
 
The FUV-ECD spectra of Trp-cage proteins (e.g. 
Exenatide, E19, E19_SS) are typically the weighted sums of the 
C-type (folded & highly helical) and U-type (unfolded) base 
curves (Figure 2/a), assigned and verified by NMR [59] [60]. As 
the temperature increases, the shape of the FUV-ECD spectra 
changes: those of the parent proteins – E2, E5, E11, E19 – 
acquire more and more U-type characteristics, as they unfold 
gradually. The temperature dependent FUV-ECD spectra for all 
4 SS-bond enforced model peptides were recorded between 
5 °C and 85 °C (by a step of 5 °C resulting in 17 spectra for each 
proteins) (SFigure 1). Aside from E2_SS, the SS-bond 
containing mutants have similar FUV-ECD spectra as their 
parent proteins at low temperatures. On the other hand, as the 
SS-bond makes the 3D-folds of disulfide variants more rigid, 
they preserve more their C-type characteristic and delay the 
unfolding even at higher temperatures. Once the SS-bond is 
reduced (see in details later), the spectral properties of the SH-
variants revert to those of parent proteins. Their 3D-scaffold 
compactness decreases as the temperature increases, less 
apparent in case of E2 & E2_2SH, as they both present – 
already at 5°C – an ensemble of dynamic backbone structures.  






Ensemble deconvolution [61][62] of the 204 (12x17) 
ECD spectra, f(λ, T), made the quantitative analysis of the 
relative abundance of secondary structural elements belonging 
to each peptide in each state possible, since as the pure ECD 
curves were successfully assigned.[59][63][64][65] The results 
indicate that Figure 2/b): i) SS-bond stabilizes the less folded 
protein scaffolds more effectively: e.g. while the difference at 
4°C between the E2 and E2_SS folded fraction is 48 %, the 
same difference between E5 and E5_SS is 14 %, in case of E11 
and E11_SS is only 28 % and last but not least for E19 and 
E19_SS is 7 %. (Figure 2/d) ii) The ratio of the folded, helical 
components increases going from E2 to E5 and E11, however 
the compact α-helix content of E19_SS, E19_2SH & E19 is 
lower than those of E11_SS, E11_2SH & E11 as the unfolded 8-
residue long N-terminal part elevates the overall backbone 
dynamics, destabilizing the compact 3D-fold. iii) All 4 reduced 
proteins (E2_2SH, E11_2SH, E19_2SH) have higher helix 
content (7–15%) than the parent proteins in a course of the 
whole temperature range. iv) 3D-folds stabilized by SS-bonds 
are less temperature-sensitive. (Figure 2/c-d) 
 
Proteins 3D-fold determined and characterized by NMR 
 
The ensemble of the temperature-dependent FUV-
ECD spectra confirms that an SS-bond preserves the model 
proteins’ fold and increases thermostability. NMR analysis 
carried out at 15°C allowed further characterization of the 3D 
structures of each variant. Fold, chemical shift and secondary 
chemical shift information [66] were derived from the appropriate 
2D-homonuclear NMR experiments (1H-1H-COSY, 1H-1H-
TOCSY and 1H-1H-NOESY) at T = 15 °C, the ensemble of the 
10 lowest energy structures were analyzed. This comprehensive 
analysis conducted at 15°C provides the following useful 
structural descriptors, the RMSD of the 3D-structures, the 





) in the helical segment and the compactness of 
the Trp-cage core by secondary chemical shift sum of selected 
protons: CSDcage. (Table 1) 
The comparison of the helices of different lengths is 
more straightforward if the helical segment is divided into four 
partitions: 1) the outer α-helix, 2) the kink region in the vicinity of 
the SS-bond and 3) the inner α-helix. (Figure 3) The outer helix  
compactness seems to be affected by the length of the -helix. 
Interestingly, this part of E11 variants is slightly more structured, 
although this segment is the terminal part (usually flexible and 
unstructured) unlike in E19 variants where this helical segment 
is flanked. (Figure 3/a) The above tendency is true for the kink-
region too, but here, the presence and state (_SS or _2SH) of 
the SS-bond also differentiates.  (Figure 3/b) These distant 
Figure 2. a) Temperature-dependent FUV-ECD spectra-series (204 in total) of the 4 primal peptides (E2, E5, E11, E19) and their 4 reduced (_2SH) & 4 oxidized 
(_SS) variants. b) The two pure ECD curves were derived from the ensemble analysis of the 204 ECD-spectra by using CCA+. Pure component 1 (red) stands 
for the unfolded/U-type, while 2 (green) for the folded/C-type backbone structure. c) The associated relative propensities (%) of the two pure components at each 
measured temperature are given for E19_SS as an example d) as well for each 204 spectra starting from E2 (at 5 °C) up to E19_SS (at 85° C). 
Table 1. Selected measures characterizing the degree of the model protein’s 
folding (T=15 °C & pH=7) 
 
[a] T= 15°C, c(protein)= 20-30 μM @ pH~7 (typical conditions applied for CD 
measurements) 
[b] calculated % from the joint deconvolution (CCA+) of 204 T-dependent FUV-
ECD spectra (c.f. Figure 2) 
[c] T= 15°C, c(protein)= 0.8-1.8 mM @ pH~7 (typical conditions applied for 
1H-
NMR measurements) 
[d] RMSD of the 10 best structure’s all backbone atoms 
[e] Xf-cage values [51][55] were used to correlate characterize protein’s fold. 
The following „H” atoms were involved in calculation: W25H1, L26H, 
G30H2, P31H2, R35H, P37HP37H2, P38H1, P38H2 
[f] The average chemical shift deviance of backbone H protons per residue 
 





) in the three different helical regions: a) outer helix (i=6), b) 














 values compared to 
those of the inner helix. The compactness of the inner helices is 
similar (expect for E2). Interestingly, reduced longer 




 values, which may 
be the indicative of ring tension in the SS-bond cyclized variants 
in these systems. (Figure 3/c) 
1H-NMR studies also confirm that all model proteins - 
except E2 - have a common, compact and folded, Trp-cage core 
structure at T=15°C (Table 1 & SFigure 2) regardless to the 
differently structured tails attached to them (Table 1). E2 is 
dominantly unfolded even at low temperature (15°C), but as SS-
bond fixes together the N- and the C-terminus of E2_SS and the 
hydrophobic core folds properly. Interestingly, even in the 
E2_2SH the A1C and A22C substitution make the Trp-cage fold 
more compact as compared to E2. In line with literature data, 
cysteines promote and stabilize α-helices, if located at their N- 
terminus. [67] The cage values of the longer reduced peptides 
are close to their oxidized counterparts (Table 1). The NMR data 
reveal that the longer the α-helix, the more structured the Trp-
cage is, in all the studied cases.  
In general, it seems that the reduced (SH-) proteins’ core 
is almost as well-folded as those of the SS-bonded. The 
following 3D-fold compactness order was established: CSDcageSS 
> CSDcage2SH > CSDcageparent, but the differences are small, aside 
from those of E2 (CSDcageE2 = 3.8) → E2_SS (CSDcageE2_SS = 
11.3).  
Oxidized and reduced states defined by NUV-ECD data 
As shown above, reduction does not have a dramatic 
effect on the tertiary structure content of the model systems at 
room temperature, thus to detect the event of reduction NUV-
ECD spectra (instead of Far-UV) had to be used. The 
interpretation of the observed chiroptical property changes of the 
Trp/Tyr/SS → Trp/Tyr/2SH (Figure 4/a) complex chromophore 
system is less straightforward, as the assignment of “pure” NUV-
ECD spectra has not yet been completed. The conformation 
dependent fine structure of Tyr/Trp chromophores [59] (260 ≤ λ 
≤ 320 nm) comprises the 1Lb of Tyr ( 276 nm with a shoulder at 
287 nm), 1Lb of Trp ( 281 and 293 nm), and 1La of Trp 
transitions appearing as superimposed broad bands. In addition, 
the SS-bond may also contribute in form of a relatively weak but 
broad band with a maximum nearby 260–270 nm. For the 
current proteins with SS-bonds a larger negative band was 
recorded (SFigure 3). The peaks of Trp and Tyr in the SS-bond 
containing proteins shifted to the negative ellipticity range, which 
was not seen in case of the parent proteins (E2, E5, E11, E19 
[59], where the bands of these amino acids have been detected 
in the positive range (except Trp band at 293nm). The 
reduction kinetics of E19_SS → E19_2SH was monitored over 
time as band intensities at 266, 281, 287, and 295 nm 
increases from larger negative to smaller negative and/or 
positive values becoming similar to those of the parent proteins. 
(Figure 4/a, SFigure 3) We were encouraged to use NUV-ECD 
spectral changes to monitor SS to SH reduction in proteins if 
embedded in a suitable molecular environment like that of the 
Tc-motif. Below we give the NUV-ECD and 1H-NMR analyses of 
the reduction of E19_SS to determine its kinetic properties.  
Due to the acidic nature of TCEP, to avoid any pH shift, 
a phosphate buffer (50 mM, pH= 7) was used and thus a near 
physiological pH was kept. Han [39] and Whitesides [37] 
described the chemical instability of TCEP above pH= 7 in 300–
400 mM phosphate buffer. They found that the autoxidation of 
TCEP depends on how the reagent is stored (open air/or capped 
vials), whether the solution is stirred and on the elapsed time (24 
≤ t ≤ 72 h) of the storage. However, here we have monitored 
TCEP stability by using 31P-NMR in 50 mM phosphate buffer, 
and found no significant spectral changes connected to TCEP 
oxidation or degradation at room temperature over 14 days.  
 
Figure 4. a) NUV-ECD spectral changes measured for the reduction of 
E19_SS ( 0.113 mM E19_SS, pH = 7, 15°C, 18xTCEP) at four different 
wavelengths (266 nm, 281 nm; 287 nm; 293 nm). No spectral changes were 
observed after 55 h (3300 min). b) 1H-NMR spectra of the E19_SS → 
E19_2SH reduction (c   0.115 mM, pH = 7, 15 °C, 18xTCEP) in water. The 
chemical shift of the indole Hε1 of Trp25 is used to monitor reduction: Hε1 
upfield shifts from 9.60 ppm (SS) to 9.78 ppm (2SH during the reduction). 
Reaching steady state the integral ratio of E19_2SH and E19_SS was found 
as 92 to 8%. c) Concentration change of E19_SS (mM) measured during 
reduction by different approaches   plotted as a function of time. d) 
Complemented with the calculated rate constants. (c.f. modeling reduction 
kinetic) 






Reduction of the E19_SS protein was followed by 
recording NUV-ECD spectra (0.113 mM E19_SS, pH= 7, 15 °C, 
18-fold excess of TCEP, cell length = 10 mm) at four different 
wavelengths (266 nm, 281 nm, 287 nm and 293 nm). Thus, by 
following band intensity changes of selected (one or more) of the 
1Lb of Tyr or Trp transitions we could monitor the redox state of 
the SS/SH-groups and determine the ‘end-point’ as a steady 
state. Thus, if a suitable aromatic residue (Tyr, Trp, Phe) is 
coupled to the SS-bond as a chromophore, it enables to monitor 
its reduction/oxidation state even when the molecular system 
shows no coupled backbone conformational changes 
(CSDcageE19_SS = 11.66; CSDcageE19_2SH = 11.07). The measured 
absorbance was converted into concentrations using the 
following equation: 𝑐(𝑡) =
A∞−A
A∞−A0
[𝑆𝑆]0. Steady state was reached 
conclusively after 55 h. We determined the rate constant k1 at 
each wavelength by parameter estimation as: k1=266nm = 4.11E–
4 Lmmol-1min-1, k1=281nm = 5.67E–4 Lmmol-1min-1, k1=287 nm = 
5.98E–4 Lmmol-1min-1. (Figure 4/c, SFigure 4) The deviations 
of the fitted model from the measured data at 293 nm were 
remarkably large; therefore, parameter estimation was not 
performed on this dataset. NUV-ECD monitoring enables to 
observe the clean and obvious changes in the spectra but it 
does not make possible to extract the absolute value of the 
concentration [SS]∞ at the endpoint of the reaction. Based only 
on the intensity of the molar ellipticity, it cannot be decided if the 
reduction is fully completed or not. To ascertain the absolute 
values of the concentrations in the redox system, reduction was 
repeated under the same conditions in 5mm Ø NMR tube 
(0.113 mM E19_SS, pH = 7, 15 °C, 18-fold TCEP) by recording 
1H-NMR resonances (Figure 4/b). By using both SS and SH 
state integrals of the signals at selected resonance frequencies 
(e.g. HεTrp), the 1H-NMR driven quantitative analysis of the 
reduction was performed (Figure 3/e) and the rate constant was 
determined as k1NMR = 8.03E–4 Lmmol-1min-1. Although 18-fold 
excess of TCEP was used, 1H-NMR data shows that at the 
steady state, ∂[E19_SS]/∂t 0 and ∂[E19_2SH]/∂t 0, reduction 
is incomplete and about 8% of E19_SS remains oxidized. 
Comparing the calculated reaction rates of the two methods 
(NMR & CD) shows that not only magnitudes are the same, but 
values can be quite similar as well. The reduction rate of NUV-
ECD measured at = 287nm is closest to k1NMR (Figure 4/c). 
Monitoring the intensity of the molar ellipticity by NUV is a fast 
and efficient method to define the end of the reaction. It also 
provides an approximate value of the reduction rate if the 
conversion is close to completion. Based on integrals of 1H-NMR, 
it is possible to determine the rate of the conversion and see 
evidence for the reversibility of the redox system as well. Taking 
into account the incomplete conversion despite the presence of 
the 18-fold excess reducing agent, the role of the dissolved 




The concept of the reversible redox system 
Physiologic solutions contain dissolved O2 from the air and 
thus Cys –SHs of any protein might oxidize spontaneously to 
SS-bond(s). The apparent rate constant depends on several 
micro equilibrium constants, explicitly not elaborated here. [68] 
However, it certainly depends on how wide the conformational 
space of the reduced molecular fold is. Furthermore, the 
concentration of the dissolved O2 (and thus, T and p), diffusion 
rate of TCEP, protein concentration are all rate influencing 
factors. As our model protein forms a coupled reaction cycle, 
once E19_2SH is oxidized, by the excess of TCEP E19_SS will 
be reduced, however, instantaneously reoxidized by the 
dissolved O2. (Figure 5) Before exploring the mechanism of this 
redox cycle related electron transfer processes, it has to be 
mentioned that at a macroscopic level, these coupled cycles 
remain hidden, as steady state (⅀∂ξ/∂t = 0) is reached. 
Reduction concludes in a “normal way” if O2 is consumed 
completely from the dissolved air. However, if the concentration 
of the reducing agent declines faster than that of O2, then 
oxidation will dominate the process and spectral properties will 
change accordingly. (Figure 5) It is hard to a priori predict the 
endpoint of the latter process, as unlike the oxidized fold of a 
protein, the reduced one could have a multitude of backbone 
conformers in exchange at a various timescale of motion (e.g. μs 
to ms). Among these 3D-folds of the reduced state the “closed-
Figure 5 a) The redox cycle schematically: The oxidized state (SS) in the presence of reducing agent (e.g.:  
TCEP), becomes reduced (2SH), where ”open & closed” conformers stand in equilibrium. In the case of the 
closed conformer, where the –SH groups are closely fixed to each other, intramolecular re-oxidation can occur 
in the presence of O2, while the open conformer is more likely to aggregate due to intermolecular interaction. b) 
Three stages of the theoretical redox setups provide the state when reduction dominates the overall process (I), 
a steady state (II) and a state (III) where the excess of dissolved O2 and the absence of reducing agent oxidize 
back the reduced state. Black square stands for the relative concentration of the oxidized form, gray diamond for 
the reduced form. If precipitation happens (k3 > 0), then at the endpoint of the redox cycle the soluble protein 
concentration decreased compared to the initial one.  
 






SH” forms (SFigure 2/II), where both the C- and N-terminus are 
close to each other, lead only to intramolecular re-oxidization. 
Furthermore, if “open-SH” backbone forms get highly populated 
(e.g. as is the case of E2_2SH SFigure 2/XIII), then 
intermolecular oxidation will be more prevalent, giving rise to 
oligo- and polymer formation. (see below)  
Capturing internal backbone dynamics occurring on the 
timescale of μs to ms of motion was successfully attempted by 
using CPMG-NMR [69]. Here we give the example of the 
successfully characterize shorter derivative E5, and its variants: 
E5_SS and E5_2SH. We found that the backbone NHs of Glu3, 
Cys4, Val5, Arg6, Tyr8 & Cys25 residues (Figure 1/b) present 
only such slower motion and only in the case of the reduced 
form E5_2SH. Considering the fact that all these NHs are close 
to both Cys residues (Figure 6), the CPMG data suggested for 
the E5_SS↔E5_2SH molecular system that using an excess of 
the reducing agent, either E5_2SH presents alternative 
backbone structures interconverting at a slow exchange rate, or 
the remaining oxidized form in trace quantity ( 1-8 % see later 
the conversion rate) constantly exchanges states with the 
reduced form. The minor coexisting oxidized form could 
contribute to the stabilization of the dominant backbone fold of 
E5_2SH. The conformational equilibrium between the oxidized 
and reduced states seems to be the most likely explanation of 
the above described slow exchange; however, both scenarios of 
motion can occur in a concerted way.  
 
Modelling of the SS-bond reduction kinetics 
 
The SS-bond reduction by TCEP is a bimolecular nucleophilic 
substitution (SN2) reaction [37]. Bimolecular by nature, both the 
concentration of the oxidized form of the protein [_SS] and that 
of the reducing agent (RA) determine the rate of the reduction. 
In an ideal case we should consider only the nucleophilic attack 
of the reducing agent (k1), but as we explained previously, in 
practice we also have to take into account the back-oxidation 
(k2) taking place simultaneously, and in some cases, depending 
on the size and shape of the protein, the precipitation (k3) 
(Figure 5). The mechanism of the reduction therefore, can be 
described by the following equations: 
SS + RAred
   𝑘1   
→   2SH + RAox 
  2SH + O2
   𝑘2   
→   SS  
  2SH
   𝑘3   
→   SSprecipitated 
Fitting this model to the NMR determined concentration-time 
functions, k1, k2 and k3 can be determined, and half-life times 
can be calculated. We focused on the determination of the 
reduction rate constants k1, therefore, the sampling was more 
frequent in the reduction phase. (Stage I. Figure 5) As a result 
of the parameter estimation (see materials and methods) k2 and 
k3 are very often either negligibly small, or – due to the lack of 
enough data – cannot be confidently estimated. Comparing 
these key kinetic parameters allows us to describe and compare 
the reduction kinetics of the SS containing miniproteins under 
various experimental conditions. Some protocols of the literature 
apply extreme conditions to obtain short reduction times, such 
as high temperature, clearly unsuitable for keeping protein’s 
integrity (e.g. 50-80°C), or > 20-fold molar excess of reagent. 
Carrying out reduction of E19_SS (0.8 mM) using such 
conditions (60 °C with 18-fold TCEP excess), the reaction 
seemed almost instantaneous (t1/2 <5 min), but the sample 
became opalescent and side reactions (e.g. precipitation) were 
instantly detected. Similarly to most globular proteins, the 
conformational ensemble of E19_2SH is distinctly different at 
60 °C compared to that at 15 °C, presenting many more 
unfolded states. The folded fraction of E19_2SH is 64 % at 
15 °C, while 41 % at 60 °C according to FUV-ECD. Instead of 
intramolecular re-oxidation, undesirable intermolecular re-
oxidation might occur between particles. (Reducing E19_SS for 
120 min, followed by centrifugation gave practically zero soluble 
protein concentration.) In general, reduction and re-oxidation at 
higher T (e.g. ≥ 60°C) is expected to be less effective, being 
accompanied by multiple side-reactions such as -elimination 
[70] (occurring already at a lower T) [71][72] , racemization 
[73][74] aggregation, etc.. In principle, the reduction rate can be 
enhanced at lower T by increasing TCEP molar ratio (15–20-fold 
molar excess); however, this also triggers obscure unwanted 
processes (SFigure 5). Experiments were repeated at different 
temperatures (15 °C, 25 °C, 37 °C) using 0.8 mM protein and 
18-fold excess of TCEP. (Table 2, SFigure 6) Arrhenius- 
equation allows deriving the activation energy (Ea) of the redox 
reaction, resulting in  44.3 kJ/mol value. For comparison, the 
activation energy of the thiol-disulfide exchange between 
methylthiolate and oxidized DTT was calculated as 62 kJ/mol. 
[75] Both FUV-ECD and NMR derived structural information 
support the high conformational similarity between E19_SS and 
E19_2SH, therefore Ea is likely to be used for the redox reaction 
rather than for the conformational switch between the two 
conformational states. (Table 1) Based on the NMR derived 
signal-integral analysis, the reduction was almost complete ( 
Figure 6. a) CPMG determined NH Rex values of E5 (red), E5_SS (green), 
E5_2SH (blue), and b) their backbone structures, with the key Cys residues 
highlighted. Slow exchange was measured for backbone NHs of E3, C4, V5, 
R6, Y8 & C25 of E5_2SH only. Note that residues giving Rex are in the 
proximity of the Cys residues colored orange. 
 
Table 2. Kinetic parameters of the temperature depending E19_SS reduction 
using 0.8 mM protein and 18-fold excess of TCEP. For the detailed results of 
parameter estimation see SFigure 6. 
 






94%) and no sign of precipitation was detected neither at any 
temperature. 
 The above described NMR methodology provides high 
resolution information about the reduction mechanism compared 
to that of the more rapid NUV-ECD approach and thus, the 
details of the reduction of all four -SS- protein models were 
completed by NMR. 
 Additional experiments were performed to investigate 
the effect of the protein/reducing agent ratio and found for the 
current protein models that i) for the initial protein concentration 
(Table 3/a) the reduction of the shortest E2 peptide in two 
different concentration was rather fast using as little as only 2-
fold excess of TCEP, while in the case of E19_SS, the 
difference between different initial protein concentration is found 
to be more relevant. (SFigure 7) Furthermore, ii) the excess of 
TCEP (Table 3/b) is such that when increasing the TCEP 
excess by 2 fold, it makes the reduction of the E11_SS 20% 
faster. (SFigure 8) Contrary to reduction of E19_SS using 17-
fold TCEP excess (SFigure 5) no additional side product was 
observed. In conclusion, it might be sensible to apply 
moderate/milder conditions to avoid any undesirable reaction 
although to reach a complete reduction might take longer time. 
 
SS-bond reduction kinetics influenced by steric factor 
 
A proper reduction protocol was required to unambiguously 
determine the 3D structures of the above introduced pure 
reduced states. Thus in line with the above only mild conditions 
(15 °C and 2-fold molar excess of TCEP) was used for reduction 
of the four different miniproteins. The knowledge of the structural 
properties and the reduction rates under the same conditions 
allowed us to elucidate the basis of the observed magnitude 
differences in their reduction rates. We have found that at T= 
15 °C, k1 of these four different length model proteins comprising 
of otherwise identical core structures are indeed different: their 
k1 and t1/2 values strongly depend on their size and/or molecular 
weights. It seems as if ‘cutting back’ the α-helical segment size 
strongly affects the SS-bond reducibility, although the SS-bonds 
of all four models are on their surfaces. (Figure 7/a). To our 
great surprise, we have got three magnitude differences 
between their reduction rate constants (Table 4). While the 
reduction of E2_SS is still extremely fast, t1/2E2_SS <  1 min, that 
of E5_SS occurs on the time scale of minutes: t1/2E5_SS  14 min. 
Table 3. SS-bond reduction as a bimolecular nucleophilic substitution (SN2) 
reaction both the concentration of the initial oxidized protein and the reagent 
influences the reduction rate. To quantify this extent a) the initial peptide 
concentrations were altered for the shortest E2_SS and the longest E19_SS 
reductions. The experiments were carried out at 15 °C, for E2_SS reductions 
2 fold of TCEP excess were used while in case of E19_SS 16 fold excess of 
TCEP. b) In case of E11_SS the excess of TCEP was altered, while 
concentration of E11_SS was set to 0.73 mM and the temperature to 15 °C. 
For the detailed results of parameter fitting see SFigure 7. 
 





[b] Half-life of E19_SS reduction by DTT was calculated according to the equation of the dependence of the half-life on outer helical length. 
 
Figure 7. a) 10 superimposed structural ensembles of E19_SS, E11_SS, 
E5_SS & E2_SS. Note that all model proteins have their SS-bond at the 
surface but their N-terminus is of different length and    charges thus, affecting 
the SS-bond reducibility. Charged residues at pH= 7, close to the reaction 
centre are explicitly depicted: the negatively charged side chains are 
highlighted by red, while the positive ones by blue. The C-terminus negative 
charge of the COO– is marked by (–) and the amino group -NH3+ of the N 
terminus by (+). Correlation between the reduction half-life b) vs. helix length 
and c) vs. steric factor (2-fold excess of TCEP, 1.7 mM protein, 15 °C) is 
reported. (SFigure 10 shows the correlation between the reduction half-life vs. 
helix length in case of DTT reductions.)  
 
Table 4. Kinetic parameters of the SS-bond reduction of the 4 model proteins. For each reduction, 1.7 mM protein concentration was used with two fold excess of 
TCEP and DTT at 15 °C. For the detailed results of parameter estimation see SFigure 8-9. NMR derived structural properties of the outer helix are also shown. 






E11_SS – elongated by 6 residues (1.5 turns of α-helix) with 
respect to E5_SS – makes a  fourfold increase in t1/2 (t1/2E5_SS  
14 min → t1/2E11_SS  67 min). Finally, the unstructured short 
octapeptide tail HAEGTFTS- further lengthens t1/2 by  13-fold 
(t1/2E11_SS  67 min → t1/2E19_SS  909 min). Conversion rate was 
close to complete for the shorter peptide of E2_SS, while the 
reduction of E19_SS was completed only to 88%.The kinetic 
parameters of all four model proteins were determined by using 
two-fold molar excess of DTT, at pH= 7 and T= 15 °C. 
Mechanism of the SS-bond reduction by DTT is also SN2 [76] 
but the determined t1/2 values are significantly longer than those 
obtained using the same molar excess of TCEP, however the 
observed overall tendency and conclusion looks the same 
(Table 4). 
As the well folded Trp-cage motive are identical (based on 
their CSD Cage values (Table 1)) in all of the 4 model proteins, 
Figure 8. The generalized mechanism of TCEP and DTT assisted mechanism of SS-bond reduction in proteins. 
Functional group R- stands for the N-terminus of the protein systematically elongated here: in E19_SS the R-group is 
equal to H+-HGEGTFTSDLSKQMEEE-, in E11: H+-DLSKQMEEE-, in E5_SS: R = H+-EEE-, while in E2_SS simply 
with H+. A brief description of the detailed reaction mechanism is provided both for TCEP and DTT in the text.  






the observed k1 differences must be associated with the 
structural properties of their α-helices and the eventually 
appearing unstructured tail. Though the dataset is limited (n = 3 
or 4), as the most simple approach, the length of the -helix (n) 
and the half-lifes (t1/2) of the reduction could be correlated 
leading to an exponential dependence in case of using both 
TCEP (t1/2 = 2.06e0,371n, R2 = 0.95) and DTT (t1/2 = 50.47e0,377n, 
R2 = 0.98) as the reducing agent. (Figure 7/b) To take into 
account the additional structural descriptors for a more complete 
characterization, we derived for these protein models the steric 





) and the bulkiness (RMSD) of the outer helical part were 
both taken into account. (Table 4) We observed a linear 
dependence of the steric factors on the reduction half-lifes as 
function of the length of the N-terminals. (Figure 7/c) Some, but 
not all of the above k1 (t1/2) differences can be explained by 
structural differences of the outer helix, as both their solvent 
exposure and local charges around the SS-bonds are different 
also. Below we summarize a mechanistic explanation, including 
all of these factors and viewpoints. (Figure 8) 
 
SS-bond reduction rate determining steric and electronic 
factors 
 
Beside the steric effect of the helical part emphasized 
above the SN2 mechanism of the TCEP driven reduction has to 
be discussed in terms of electrostatic effects. [19] In general, the 
attack is more favorable and effective on those structures where 
the C-terminus is neutral. According to the average pKa of the 
cysteine carboxyl group (pKa = 1.92) at pH= 7, the proportion of 
COOH/COO– is low: 1/12000. The rate determining step is the 
cleavage of the SS-bond. [77] During the SN2 reaction, the 
nucleophilic P-atom of the TCEP attacks one of the SS-bonds, 
forming a thiophosphomium salt (an S–-P+ ion-pair complex) 
(Figure 8).  
Nucleophilic attack (n → σ*) is facilitated by the 
favorable arrow shape (tetrahedral: 105°) steric arrangement of 
the non-bonding electron-pair of the P-atom of TCEP. Because 
the three -COOH groups of TCEP are H-bonded at pH= 7, 
though not taking part of the reaction, their orientation enhance 
the P-nucleophile [38] and also increase the proton activity. The 
main portion of the activation Gibbs-free energy of the reduction 
is consumed by the splitting of the SS-bond and not by the steric 
rearrangement of the intermediate structure. [78] The better (the 
thiol and) the zwitterion solvated, the lower the activation Gibbs-
free energy of the reaction is. Next the positively charged -S-P+-
[(CH2)-COOH]3 complex hydrolyzes rapidly and results in the 
phosphine oxide and the free –SH groups of the protein. 
However, all charged amino acids in the sequential 
and /or spatial vicinity of an SS-bond should be considered, as 
both charged and aromatic side chains can participate and thus, 
intimately influence the efficacy of TCEP mediated reduction 
(Figure 7/a). The nucleophile phosphine attacks the C-proximal 
cysteine because the intermediate cation can be stabilized by 
the proximal COO– group of the C-terminal cysteine. A positive 
charge nearby the SS-bond could enhance the reaction via 
electrostatic compensation of the N-proximal leaving thiolate 
group, while a negative charge might slow down the SN2 
reaction. [79][80] Direct through-bond effects of any charged 
side-chain can be ignored as they are separated by several σ-
bonds from the negative COO–. While the inductive or direct σ-
bonds effects are negligible, both steric and spatial electrostatic 
effects in the vicinity of N-proximal cysteine play a major role on 
the reduction rate. 
The positively charged Arg at pH= 7 nearby the SS-
bond in the inner helix may facilitate the reduction; however, it is 
away from the SS-bond (Figure 7/a), thus a direct charge-
controled interaction is less likely to occure. On the other hand, 
the positivly charged N-terminus -NH3+ can directly catalyze the 
instantaneous reduction [81] of E2_SS (t1/2E2_SS 1 min) as H-N-
CCS of the cysteine forms a 5-member pseudo-ring 
facilitating intramolecular NS proton transfer. [82] Thus, when 
TCEP attacks, presumably these ideal local electrostatic 
compensations stabilize the intermedier thiophosphonium salt by 
shifting the reaction equilibrium towards the splitting of the SS-
bond. Not alone the optimally positioned charges nearby the SS-
reaction center make the reduction conditions favorable for 
E2_SS. As the N-proximal leaving thiolate anion is positioned 
just at the N-terminal of the well folded -helix, the positive 
charge of the -helix macro-dipole stabilizes the intermediate 
structure. [83][84] Moreover, due to the small protein size the 
SS-bond is the most exposed to solvent and reagent in E2_SS.  
As the N-terminus gets elongated lengthening the α-helix 
from E2_SS toward E19_SS, the “catalyzer” –NH3+ group of the 
N-terminus gets further away from the SS-bond and the effect of 
the macro-dipole gradually vanishes and thus, reduction rate is 
reduced (t1/2 increases). (Table 4) The role of this positive 
charge was directly probed by acetylating the N-terminus, Ac-
E2_SS, and as expected, half-time of the reduction increased 
significantly: t1/2E2_SS 1 min → t1/2Ac-E2_SS 8 min. (In both cases 
1.7 mM protein concentration and 2-fold excess of TCEP was 
used.) 
The N-terminal elongation of E2_SS by three Glu residues 
results E5_SS. As expected, reduction rate gets slower: t1/2E5_SS 
14 min. Although only a tripeptide is added to the dynamic N-
terminus, it makes harder for both reagent and/or solvent 
molecules to reach the SS-bond. In addition, the 3D-structure 
(Figure 7/a) shows that the three negatively charged Glu side 
chains (at pH = 7) are flanked by the N-proximal cysteine and 
the positively charged N-terminus and thus, effectively 
neutralizes the catalytic effect. NMR structure ensemble shows 
a 3.7 Å ↔ 10.7 Å distance fluctuation between 4Cys C and 
1Glu NH3+, while that of 4Cys C and 1Glu COO– fluctuates 
between 3.4 Å and 12.4 Å. (Figure 7) Thus, SS-bond 
protonation requires the active contribution of the medium; but 
the proton transfer is perturbed by the proximity of the 
glutamates negative sidechains.  
Further elongation of E5_SS by hexapeptide -
DLSKQM- leads to E11_SS. Using the same conditions, the 
reduction of this even larger model protein occur slower 
(t1/2E11_SS  67 min). The glutamate sidechains of E5_SS are 
more oriented by the longer α-helix of E11_SS (Figure 7): while 
8Glu– turns outward, both 7Glu– and 9Glu– flanks from both side 
the SS-bond. 7Glu– with 4Lys+ and 9Glu– with 12Arg+ are 
capable to form salt-bridges in close vicinity, thus could partly 
compensate the slowing effect of the flanking negative 
sidechains. E11_SS has the more compact α-helical segment 
among these model proteins, as perhaps the negatively charged 
side-chain of 1Asp– self-compensates with its own N-terminus –
NH3+. E11 was found to be more helical than the longer E19 [56], 
thus we find here that both E11_SS and E11_2SH have more 





 NMR-measure and the FUV ECD-spectral 
properties. We think that beside the partly compensated 
negative electrostatic effect(s), mainly the steric effects of the 
elongated and stiffer α-helix causes the longer t1/2E11_SS with 
respect to t1/2E5_SS. 
Finally E11_SS elongated by the -HGEGTFTS- 
octapeptide results in E19_SS, the largest model protein used 
here for which the longest half-life (t1/2E19_SS = 909 min) is 
measured. As E19_SS has the same electrostatic pattern in the 
vicinity of the SS-bond as that of E11_SS nevertheless, its 
reduction rate is about 15 times slower than that of E11_SS. As 
-HGEGTFTS- segment is far from the SS bond, it cannot 
influence the reduction by electrostatic interaction, (d7Thr-18Cys: 
11-14 Å, Figure 7) its higher internal dynamics (low S2 value) 
[56] – as a steric effect – must slow SS-bond reduction rate 
further. In fact, the latter increase in terms of t1/2 is a good 






estimation of the magnitude of a purely steric effect of an 
unstructured polypeptide chain on reduction rate.  
Differences in reduction kinetics and mechanism by using 
alternative reagents 
 
There are a few distinct differences in terms of general 
mechanism of disulfide reduction by TCEP and DTT. (Figure 8) 
i) As an initializing step, the deprotonation of the thiol group of 
DTT is required for a successful nucleophile attack, which 
depends on the pH of the medium. According to the Henderson-
Hasselbach equation [85] and the acidic dissociation constant of 
the DTT (pKa1 = 9.2 and pKa2 = 10.1), at pH = 7, the 
deprotonated thiolate concentration is about 3–4–fold lower than 
that of the overall DTT concentration. After the successful 
nucleophile attack on the SS-bond, a linear -S-S-S- transition 
complex has to be formed in which the negative charge is 
located on the two leaving S-atoms. [86] An intramolecular 
protonation, as for TCEP, also stabilizes the thiol anion leaving-
group when DTT is used, and thus enhances the reaction rate. 
Therefore, a positive inductive/steric effect increases, while a 
negative decreases the reduction rate. ii) Contrary to TCEP, the 
active species of DTT bears a negative charge. Therefore, 
charged amino acid side chains close to the SS-bond will 
directly affect the attack of the nucleophile reducing agent. In 
line with these, both the negative C-terminus and the SS-bond 
flanking glutamate side chains repel DTT contributing to a 
significant and large-scale reaction rate decrease. (Table 4) iii) 
Moreover, the complete reduction by DTT consists of two steps: 
after the first attack, the free SH-group of the peptide-DTT 
complex has to cleave the previously formed SS-bond, while the 
DTT closes into a six-member ring. (Figure 8) All these factors 
jointly decrease reduction rate when DTT is used compared to 
TCEP (Table 4). However, these considerations stand contrary 
with general practice: several proteins of various numbers of 
disulfide bonds per molecule – like -lactalbumin, lysozyme, and 
oxytocin – can completely be reduced in 5 minutes by 10 mM 
DTT in pH = 5.5 ammonium-acetate buffer at 70 °C. [87] 
 
Spontaneous SH re-oxidation accompanied by 
polymerization 
The incomplete conversion despite the presence of a 
large excess of the reducing agent showed evidence for the re-
oxidation of the reduced disulfide bond of the studied model 
systems. To study this process in more detailed, the in situ re-
oxidation of the DTT reduced protein samples at room 
temperature in a sealed NMR tubes (pH = 7, 15 °C, 2-fold 
excess of DTT) was monitored for several weeks. Spontaneous 
re-oxidation of the E2_2SH, E5_2SH, E11_2SH by the dissolved 
O2 was obvious after 4 weeks. (Figure 9) The re-oxidation rates 
(k2) have comparable order of magnitude to the reduction rates 
(lower by one order of magnitude), but the re-oxidation has a 
pronounced role only after reaching the steady-state, when the 
concentration of the already reduced peptides become 
significant.  
Re-oxidation can take place both intra- and inter-
molecularly. While the former leads to the decrease of overall 
conversion rates the latter results in formation of random 
molecular cluster which may lead to precipitation. According to 
our semi-quantitative analysis based on the recorded 1H-NMR 
spectra, the integral changes of the Trp H1 resonances both in 
the oxidized and reduced form of the protein during reduction 
with DTT show a decrease in concentration over the observed 
period of redox time both for E2_SS and E5_SS. Precipitation 
can be more intense if protein concentration is higher. According 
to our present observations, increasing the length of the -helix 
within the Trp-cage proteins stabilizes the soluble protein 
fraction. This means, that the elongated N-terminus, namely the 
outer helix in case of E11_2SH, effectively shields the free SH-
groups of the reduced protein and thus, prevents any 
intermolecular re-oxidation, while shorter variants like E2_2SH 
and E5_2SH yield to a significant amount of polymer formation. 
Due to the diversity of opened 3D-folds of both E5_2SH, 
E2_2SH the spontaneous intramolecular ring-closure is hindered 
and less likely to happen. The N-terminal Cys of E11_2SH is 
placed and fixed at the highly ordered inner-helix, with a reduced 
internal mobility of Cys18, and thus mostly intramolecular ring 
closure takes place. In case of E5_2SH intermolecular SS-bond 
formation is allowed, but may limited just by the Brownian 
motion and the concentration. Comparison of the polymerization 
rates (k3E11_SS < k3E5_SS) with the different N-terminal lengths 
supports also this concept. (Figure 9/e) 
E2_SS was N-acetylated to eliminate the reduction 
rate enhancing effect of the positively charged N-terminus, -NH3+, 
in the vicinity of the SS-bond. Upon acetylation, t½ has indeed 
increased (t½E2_SS= 1min  t½E2_SS= 8min); but in addition, the 
reaction reached its steady-state at a low conversion rate: 50%. 
During reduction, almost immediately both of the appropriate 
signal integrals of Ac-E2_SS and Ac-E2_2SH started to 
decrease, with a foamy precipitate gradually sedimenting in the 
NMR tube. The isolated and HPLC purified precipitant was 
identified as a polymer of the parent miniprotein by MS. 
(SFigure 12) Oligomer formation and soluble protein 
concentration decrease was more advanced for Ac-E2_SS 
compared to E2_SS. (SFigure 13) Due to the absence of the 
shielding effect of the outer -helix, the free thiol moiety of the 
N-terminus is accessible for additionally reduced peptides where 
the two free SH-groups after oxidation hook peptid chains 
together. The polymer can grow until another free N-terminus 
and acetylated C-terminus thiol-containing peptide closes 
Figure 9. The 50 membered structure ensemble of a) E11_SS ⇋ E11_2SH 
and b) E5_SS ⇋ E5_2SH. The fold of E11_2SH is more compact than that 
of E5_2SH, which has more “opened’ conformers, where the Cys residues 
get far from each other. This allows intermolecular re-oxidation instead of 
intramolecular one. The dissolved oxidized and reduced protein 
concentrations of c) E11_SS ⇋ E11_2SH and d) E5_SS ⇋ E5_2SH 
(oxidized: blue; reduced: green) as a function of time. In case of E5_SS ⇋ 
E5_2SH, the initial concentration decreased by 68%, while at the end of a 
complete redox-cycle, the concentration of E11_SS ⇋ E11_2SH remains the 
same. e) Estimated parameters of the complete redox cycles. (k1 values are 
slightly different compared to those in Table 4, where the estimation 
comprises data only for phase 1.) Note that, in these long-term experiments, 
the rate of O2 diffusion characterized by the rate constant k4 was also 
involved. SFigure 11 contains all data of parameter estimation for E11_SS, 
E5_SS, E2_SS. 






polymerization. In addition, for Ac-E2_2SH, the intramolecular 
N→S acyl transfer could take place [88] blocking some of the 
SH-groups promoting oligo- and polymerization via 
intermolecular SS-bond formation.  
Conclusions 
Disulfide-bond cyclized Exenatide derivate and its 
variants were synthesized. Both the oxidized (E19_SS) and the 
reduced form (E19_2SH) along with the parent molecule, E19, 
and all three of their truncated variants (E11_SS, E11_2SH, E11, 
E5_SS, E5_2SH, E5, E2_SS, E2_2SH and E2) comprise the 
very same Trp-cage/SS/SH-bond motif as their core structures. 
The SS-bond stabilized model proteins showed improved 
thermo-stability and 3D-fold compactness with respect to their 
reduced and parent forms. Key residues for the receptor binding 
remain in position in all of these models; therefore E19_SS 
might be promising agonists for GLP-1 receptor and thus, for 
developing as lead compound for type 2 Diabetes Mellitus.  
The reduction rate of the E19_SS was found to be 
unexpectedly slow compared to literature data. The reaction 
took hours (t1/2 = 48 min) even at 37 °C, although the protein is 
small and it’s single SS-bond is exposed at the surface and is 
thus accessible for reducing reagents. All four Trp-cage variants 
studied in this work have an almost equally compact core-
structure with α-helical segments of different length and internal 
mobility. By performing a complete NMR-based structure 
elucidation, we found that the progress of reduction can be 
monitored by 1H-NMR using selected resonance frequencies. 
We have established that these four model proteins of different 
α-helical lengths have significantly different reduction rate 
constants. Although it is generally complicated to discriminate 
each factor affecting the SS-bond reduction rate, the present set 
of miniproteins of different length enables to decipher them 
separately. We have focused special attention to the importance 
of the intramolecular protonation of the SS-bond: a step greatly 
enhancing the reaction rate. Using CPMG-measurements we 
found that at the steady state, selected residues at the vicinity of 
the SS-bond present a slow exchange at the s-ms timescale of 
motion. This redox cycle lasts as long as the active reducing 
agent can be found in the solution. We found that structural, 
steric and electrostatic factors influence the reduction rate 
greatly, resulting in almost 3 orders of magnitude differences in 
reduction half-times (t½), for otherwise structurally similar and 
globularly folded model proteins.  
Notably, in addition to the intramolecular re-oxidation 
within the redox cycle, intermolecular oxidation could also occur. 
The rate of these two concerted reactions depend on 1) the 
internal dynamics of the backbone conformers at the SS-bond 
proximity and 2) the shielding effect of the -helix on the SS-
bond. Intramolecular N→S acyl transfer in Ac-E2_SS inhibits the 
intramolecular, while increases the intermolecular re-oxidation, 
which leads to oligo- and polymerization.  
We found that easy to collect NUV-ECD spectral 
properties are indeed useful for monitoring the SS→SH reaction 
even quantitatively, without the time-consuming assignment of 
the high resolution NMR data. If the SS-bond is situated in 
vicinity of an aromatic cluster, NUV-ECD spectral changes can 
be used to monitor the transformation being proportional to the 
extent of the reduction and clearly signalling when steady-state 
is reached. Thus, we encourage the use of CD-spectroscopy for 
monitoring protein reduction rate when manufacturing 
recombinant proteins (e.g. Insulin, human monoclonal IgG 
antibodies) on a large scale to control and provide information 






Parent model proteins: E2, E5, E11 and E19; SS-bonded / 
oxidized model proteins: E2_SS, E5_SS, E11_SS and E19_SS; 
Reduced model proteins: E2_2SH, E5_2SH, E11_2SH and 
E19_SS; TCEP: Tris-(2-carboxyethyl)-phosphine; DTT: 1,4-
Dithio-D-threitol; ECD: Electronic circular dichroism 
spectroscopy; FUV: Far UV range; GLP-1: Glucagon-like 
peptide-1 IgG: Immunoglobulin G; NUV: Near UV range; RMSD: 
Root-mean-square deviation of atomic positions; S-S, SS: 
disulfide bond; SCS: Secondary chemical shift; CSD: Chemical 
shift deviation; CPMG-effect: Carr-Purcell-Meiboom-Gill-effect / 
experiment; NMR: Nuclear magnetic resonance spectroscopy; 
Trp-cage, TC: Tryptophan-cage 
 
Electronic Circular Dichroism:  
Far-UV ECD spectra were recorded on a Jasco J810 
spectrophotometer using 1.0 mm path length cuvette with 
protein concentration 20-30 M. Data accumulation were 
performed over a range of 185-260 nm with 0.2 nm step 
resolution where the scan rate 50 nm/min with a 1 nm bandwidth. 
The spectra accumulations were absolved between 5°C – 85°C 
per steps of 5°C. The temperature was controlled by a Peltier-
type heating system. Each spectrum baselines were processed 
by subtracting the solvent spectra from that of the protein and 
the raw ellipticity data were converted into mean residue molar 
ellipticity units [MR.  
Reduction monitoring by Near-UV ECD: spectra were 
recorded on a Jasco J810 spectrophotometer using 10 mm path 
length cuvette with protein concentration 120-150 M. Data 
accumulation were performed over a range of 240-325 nm with 
0.2 nm step resolution where the scan rate 50 nm/min with a 1 
nm bandwidth. The sample was tempered by a Peltier-type 
heating system. Each spectrum baselines were processed by 
subtracting the solvent spectra from peptide spectra and the raw 
ellipticity data were normalized by the concentration [The 
reduction was followed for 75 hours. Each intensity [at 266nm, 
281nm, 287nm & 293nm were converted into concentration 





Nuclear Magnetic Resonance:  
All 1H experiments were performed on a Bruker Avance III 700 
MHz equipped with z-gradient 5-mm probe-head operating at 
700.13 MHz for 1H, while 31P experiments were carried out on a 
Bruker Avance 250 spectrometer with 5mm SB quad probe-
head. 
Monitoring reduction kinetic. Peptide samples were prepared 
between 0.8-1.8 mM dissolving in 600l of 50mM, pH=6.95 
NaH2PO4-Na2HPO4 buffer, with 10% D2O. 0.1 M NaOH was 
used to set the pH to 7. DSS was added as the internal proton 
reference standard set to 0.0 ppm under all conditions. 1H-1H 
2D-homonuclear spectra were recorded from the oxidized 
peptide, thereafter adding a different excess of 0.5M TCEP or 
DTT the reduction was observed by 1D 1H spectrum series 
(ns=64 or 128 scans), finally at the endpoint 1H-1H homonuclear 
2D spectra were recorded from the reduced peptide. Data sets 
were processed using TopSpin 3.2. The conversion rate was 
determined using the relative integral of the Trp H1 peak in the 
oxidized (IntOX) and reduced (IntRED) form. Each integral were 
normalized to the integral of the DSS. The concentrations were 
determined by the ratio of the oxidized and reduced integrals 
and the initial protein concentration. 
Structure determination: Proton NMR assignations were 
completed using 1H-1H COSY and 1H-1H TOCSY spectra, then 
the distance restraints were determined based on 1H-1H NOESY 
spectra. Spin locks for 1H-1H TOCSY were 80ms while the 
mixing time for 1H-1H NOESY were 150ms. CCPNMR [89] was 
used for resonance assignment, cross-peak calibration and 






structure refinement. CNS Solve 1.3 [90], Aria 2.0 standard 
iteration protocol and water refinement were used for 10-
membered structure ensemble calculation. All structural figures 
are illustrated using Pymol software.  
CPMG effect: Backbone 15N-longitudinal (R1) and transverse 
(R2) relaxation rates and the heteronuclear 1H−15N cross-
relaxation rate constant (NOE) of E5, E5_SS, E5_2SH were 
measured at 288K. For each cross-peaks (i) R2,i values were 











where 𝐼𝑖  is the intensity of the given cross-peak in the i-th 
spectrum, 𝐼𝑟𝑒𝑓  the intensity of the given cross-peak in the 
reference spectrum, 𝑡𝐶𝑃𝑀𝐺 is the relaxation period of the CPMG 
measurement. The R2 values per residues were plotted against 
the 𝜈𝐶𝑃𝑀𝐺 (Hz). Quantitative analysis of the CPMG graph results 
those residues that show CPMG-effect in the protein.  
 
Peptide synthesis and purification:  
Proteins were prepared by standard solid-phase peptide 
synthesis or bacterial expression methods as we published 
previously. [91] Proteins were purified by reverse-phase HPLC 
using C-18 column using a gradient of water/acetonitrile eluents. 
(Eluent A: 0.1% TFA in water and eluent B: 0.08% TFA and 80% 
acetonitrile in water.)  
 
Parameter Estimation:  
Kinetic parameter estimation was based on the integral of 
selected NMR signals considered to be proportional to the 
concentration of the relevant species. The mechanism taken into 
account is the following: 
SS + Red 
    𝑘1    
→    2SH + Ox 
2SH + O2 
    𝑘2    
→    SS 
2SH 
    𝑘3    
→     
 
    𝑘4    
→    O2 , 
where SS is the reduced model protein with an intramolecular 
S–S bond, 2SH is the same protein with the S–S bond reduced 
to two –SH groups, and the symbol  means a different phase 
than the reaction mixture; i. e. the polymer aggregate as a sink 
in the first and the gas phase as a source in the second case. 
Note that in some cases – where polymer precipitation (k3) 
and/or oxygen diffusion (k4) from the gas phase proved not to be 
present (indicated by largely non-significant estimated 
parameters concerning these processes) – these steps have 
been omitted from the fitted mechanism. 
For the parameter estimation the COPASI 4.16 (Build 104) 
Biochemical System Simulator software (http://copasi.org/) was 
used, with the parameter estimation option of the Levenberg-
Marquardt method. The result of the estimation procedure did 
not depend on the choice of the initial parameters within a large 
interval, thus there was one stable optimum for the fit of the 
model only. Confidence interval half-widths and relative standard 
deviations based on them were calculated from the estimated 
standard deviations suggesting Student distribution with n – p 
degrees of freedom, where n is the number of data in the 
concentration vs. time measurements and p is the number of 
parameters estimated.  
To determine the half-life and initial concentration of 
the SS species, a kinetic analysis of the temporal evolution of 
the reactions was performed. Both reduction and oxidation 
proved to be second order reactions, which was not only 
supported by the good fit of the model but also by the fact, that – 
using this mechanism – the measured ([SS]0,meas) and calculated 
([SS]0,calc) initial concentrations of the model proteins were in 
very good agreement. From the kinetic analysis, the initial 
concentration of oxygen ([O2]0) could also be estimated, except 
for one case where the uncertainty of this parameter was very 
large, due to the lack of enough experimental data.  
As the reduction follows second-order kinetics, the 
half-life (t1/2) of model proteins depends also on the actual 
concentration of the reducing agent in the reaction mixture as 
follows: 
𝑡1/2 =
 1  





where k1 is the rate constant of the reduction, cSS,0 is the initial 
concentration of the model protein, and cRed,0 that of the 
reducing agent. (Note that this formula is valid only if cRed,0 is 
greater than cSS,0 – as in the current case. If cSS,0 exceeds cRed,0 
but it is not higher than twice the value of cRed,0, then the two 
initial concentrations should be flipped in both the difference and 
the fraction. If cSS,0 exceeds cRed,0 by more than a factor of 2, 
then the SS protein concentration cannot become as low as half 
of the initial concentration, due to the reduction.) For this reason, 
the half-life is less indicative concerning the rate of the 
hydrolysis; the correct comparison of the rates can be made 
based on the rate constant(s) of the second-order reaction(s).  
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Structural, steric and electrostatic factors influence the SS-bond (yellow-spheres) reduction rate resulting in 3 orders of magnitude 
differences in reduction half-times (t½) in case of N-proximal truncated SS-bond cyclized Exenatide derivates. 
 
 
